We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Upholds Invalidation of Janssen’s Razadyne Patent
Appeals Court Upholds Invalidation of Janssen’s Razadyne Patent
September 29, 2009
A federal appeals court has upheld a ruling favoring generic-drug makers in a patent case involving Janssen Pharmaceutical’s Alzheimer’s disease drug Razadyne.